Serum Protein Thiol Levels in Patients with Hospital-Acquired Acute Kidney Injury

Kidney Blood Press Res. 2015;40(6):623-9. doi: 10.1159/000368538. Epub 2015 Dec 17.

Abstract

Background/aims: This study aimed to examine antioxidants in patients with acute kidney injury (AKI) and determine whether serum protein thiol levels are associated with all-cause 90-day mortality in patients with hospital-acquired AKI.

Methods: According to the RIFLE criteria, 160 patients with hospital-acquired AKI were enrolled in our prospective cohort study. As controls, 72 critically ill patients without AKI and 72 age and sex-matched healthy subjects were also recruited. Serum protein thiol levels were analyzed in relation to all-cause mortality of patients with AKI.

Results: Serum protein thiol levels in AKI patients were lower than those in healthy people (p=0.010). Protein thiol levels showed a weak but significant positive correlation with serum albumin levels. The 90-day overall mortality rate was higher in AKI patients with high serum protein thiol levels than in those with low levels (p=0.032 by log rank test). In multivariate analysis (Cox regression), serum protein thiol levels (p=0.031) were independently associated with 90-day overall mortality after adjustment for age, sex, sepsis, and the Acute Physiology and Chronic Health Evaluation II score.

Conclusions: Patients with hospital-acquired AKI have remarkably low serum protein thiol levels. Elevated protein thiol levels are associated with 90-day overall mortality in hospital-acquired AKI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • APACHE
  • Acute Kidney Injury / blood*
  • Acute Kidney Injury / mortality*
  • Adult
  • Aged
  • Blood Proteins / analysis*
  • China / epidemiology
  • Cohort Studies
  • Critical Illness / mortality
  • Female
  • Hospital Mortality
  • Humans
  • Iatrogenic Disease*
  • Male
  • Middle Aged
  • Prospective Studies
  • Risk Assessment
  • Serum Albumin / analysis
  • Sulfhydryl Compounds / blood*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Blood Proteins
  • Serum Albumin
  • Sulfhydryl Compounds